XML 22 R12.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Cash and Marketable Securities
 3 Months Ended
Mar. 31, 2024
Cash and Cash Equivalents [Abstract]  
Cash and Marketable Securities CASH AND MARKETABLE SECURITIES
Cash, Cash Equivalents and Restricted Cash
A reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets to the amount reported within the condensed consolidated statements of cash flows is shown in the table below (in thousands):
March 31, 2024March 31, 2023
Cash and cash equivalents$93,299 $74,660 
Restricted cash583 520 
Total cash, cash equivalents and restricted cash at the end of the period
$93,882 $75,180 
Marketable Securities
All short-term marketable securities were considered held-to-maturity at March 31, 2024. At March 31, 2024, some of the Company’s short-term marketable securities were in an unrealized loss position. The Company determined that it had the positive intent and ability to hold until maturity all short-term marketable securities that have been in a continuous loss position. The Company assesses whether the decline in value of short-term marketable securities is temporary or other-than-temporary. In making its assessment, the Company evaluates the current market and interest rate environment as well as specific issuer information. There was no recognition of any other-than-temporary impairment at March 31, 2024. All short-term marketable securities with unrealized losses as of the balance sheet date have been in a loss position for less than twelve months. Contractual maturities of the short-term marketable securities were within one year or less.
The long-term marketable equity securities were recorded at fair market value with changes in the fair value recognized in earnings at March 31, 2024 and December 31, 2023. The long-term marketable debt securities were considered available-for-sale at March 31, 2024 and December 31, 2023. The contractual maturity of the long-term marketable debt securities are less than three years.
The amortized cost, gross unrealized holding gains and fair value of the Company’s marketable securities by major security type at each balance sheet date are summarized in the tables below (in thousands):
March 31, 2024
Amortized Cost
Unrealized Holding Gains, Net
Fair Value
Short-term marketable securities:
U.S. agency securities$79,603 $640 $80,243 
Corporate debt securities43,019 587 43,606 
Total short-term marketable securities$122,622 $1,227 $123,849 
December 31, 2023
Amortized Cost
Unrealized Holding Gains, Net
Fair Value
Short-term marketable securities:
U.S. agency securities$80,468 $2,038 $82,506 
Corporate debt securities72,753 711 73,464 
Total short-term marketable securities$153,221 $2,749 $155,970